blood transfusions: everything you’ve always wanted...
TRANSCRIPT
1
Blood Transfusions:
Everything You’ve Always Wanted to Know, But Didn’t Know Who to Ask
Anne Eder, MD PhD
Executive Medical OfficerAmerican Red Cross
National Headquarters, Biomedical ServicesWashington, D.C.
Whole Blood Composed of:
Liquid Plasma
CellularPlateletsWhite Cells
NeutrophilsLymphocytesMonocytes
Red cells
Buffy coat
Hematocrit38-45%
Peripheral Blood Smear (CBC)Red Cells
Hemoglobin Men: 16 + 2 g/dLWomen: 14 + 2 g/dL
White Cells
Platelets
Women: 14 + 2 g/dL
4,500 – 11,000 WBC/μL
150-400,000 platelets/μL
2
Red Cells (Erythrocytes)Carry oxygen to tissuesRemove carbon dioxide from tissues
Red Cells (“Packed RBC”)~14 million units/year in U.S.Usually stored for 5-6 weeks at 4-10oC
Red Cells (Erythrocytes)Transfusions are used to treat:
Active bleeding (hemorrhage)SurgeryTraumaTrauma
Anemia Decreased RBC production
e.g. chemotherapy, bone marrow failureIncreased RBC destruction
e.g. sickle cell anemia
Expected response to transfusion:1 RBC unit increases hemoglobin by 1.0 g/dL
White Cells (leukocytes)Fight infections
Engulf (phagocytize) bacteria to destroy themGenerate antibodies
WBCs in RBC or platelets can cause transfusion reactions F b il h l ti tiFebrile nonhemolytic reactions Cytomegalovirus infectionAlloimmunization
Component preparation Leukoreduction removes 99.9% WBC Irradiation inactivates WBC (lymphocytes); prevents TA-GVHD
Rarely, WBC (neutrophil) transfusions to treat life-threatening infections that don’t respond to standard treatment if marrow recovery is expectedTypically 1 WBC per 1000 RBC
3
Platelets (thrombocytes)Important in clotting (stop bleeding)
Secrete serotonin, which constricts blood vessels to slow bleedingActivate plasma proteins that form fibers which serve as a net toActivate plasma proteins that form fibers, which serve as a net to stop leaking red cells.
Smaller than RBCs on a peripheral blood smearCan only be stored for 5 days with continuous gentle agitation at 20-24oC Typically 25 platelets per 1000 RBC
Clotting Schematic
PlateletsPlatelets
Fibrin
EndotheliaCollagen
Ody
ssey
Mag
azin
e, 2
010
Normal: 150-400,000/μl
Platelet Count and Bleeding
Gaydos et al NEJM 1962 Slichter and Harker1978
4
Petechial Hemorrhage
Platelet therapySingle donor platelets (SDP)
Apheresis yields 1-3 doses
Whole Blood Platelets“R d d l t l t ” (RDP)“Random donor platelets” (RDP)4-6 products pooled for 1 dose
Prophylactic use for low platelet count (thrombocytopenia)Therapeutic use to stop bleeding
Expected response to transfusion (adults): • 1 RDP unit increases platelet count by 5,000-10,000 /µL • 6 RDP units (1 pool) or 1 SDP by 30,000 -60,000/µL
PlasmaYellowish fluid, approx. 55% of whole blood donation Contains antibodies, clotting factors
Normal Plasma
Used to treat bleeding patients with multiple clotting factor deficiencySource for further fractionation (separation) for factor concentrates (e.g., Factor VIII)
Expected response to transfusion (adults): • 1 plasma unit (~250 mL) - 1 unit/mL clotting factors; 400 mg
fibrinogen; clinical response monitored by PT, PTT or bleeding
5
Blood BankingThe process of collecting, manufacturing, testing, storing and distributing blood products for patient care
Apheresis Donation (e.g., platelets)
ABO, Rh (blood type), Ab screenHepatitis B HBsAg, Anti-HBc, Nucleic Acid Test Hepatitis C Antibodies, Nucleic Acid TestHIV 1/2 A tib di N l i A id T t
Every Donation is Tested
HIV 1/2 Antibodies, Nucleic Acid TestHTLV I and HTLV-II AntibodiesSyphilis AntibodiesWest Nile Virus Nucleic Acid TestT. cruzi (Chagas) AntibodiesBacteria Platelets onlyOptional CMV (Cytomegalovirus) Antibodies
Sickle cell trait Screen for hemoglobin S
6
Transfusion-transmitted Infections
Risk of a potentially infectious unit is calculated from mathematical models:
Hepatitis B 1: 282 000Hepatitis B 1: 282,000Hepatitis C 1: 1,149,000HIV 1: 1,467,000
Lookback and investigations of suspected infections suggest risk is even lower (4 cases of transfusion-transmitted HIV have been documented since NAT introduced in 2004)
Red Cell Compatibility: Blood type
(RBCs)Plasma
antibodiesFrequency (%) Compatible RBC
transfusion
O Anti-A, anti-B 45% OA A ti B 41% A OA Anti-B 41% A or OB Anti-A 10% B or O
AB None 4% All (A, B, O or AB)
..if INCOMPATIBLE….Agglutination and Hemolysis
A anti-BAA
ABanti-B
BGroup A
Febrile 1:100Allergic 1:100
Anaphylaxis 1:20,000 to 50,000V l l d 1 100 t 1 200
Noninfectious Complications
Volume overload 1:100 to 1:200Septic (bacteria) 1:5,000,000 (red cells)
1:250,000 (apheresis platelets)
TRALI 1:440,000 (red cells)1:250,000 (plasma, male predominant)
Hemolytic – acute (ABO incompatible)
1:12,000 to 1:38,000
Hemolytic - delayed 1:5400 to 1:62,000
7
Symptoms Differential DiagnosisFever Acute hemolytic reaction (ABO incompatible)
Febrile nonhemolytic reaction Sepsis (bacterial contamination of unit)
Every transfusion should be monitored…..
Hives, itching Allergic transfusion reactionDifficulty breathing Allergic transfusion reaction
Transfusion-associate circulatory overloadTransfusion-related acute lung injury
Lower back pain Acute hemolysis (ABO incompatible) Delayed hemolysis
Questions?
Anne Eder, MD PhD
Executive Medical OfficerAmerican Red Cross
National Headquarters, Biomedical ServicesWashington, D.C.
EderA @ usa.redcross.org